4/A//SEC Filing
BUZY PETER L 4/A
Accession 0001596783-19-000192
CIK 0001596783other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 12:20 PM ET
Size
6.4 KB
Accession
0001596783-19-000192
Insider Transaction Report
Form 4/AAmended
Catalent, Inc.CTLT
BUZY PETER L
President, Gene Therapy
Transactions
- Award
Options to purchase Common Stock
2019-05-17+231,700→ 231,700 totalExercise: $0.87From: 2019-05-17Exp: 2024-12-16→ Common Stock (231,700 underlying)
Footnotes (1)
- [F1]Options to purchase common stock received by the reporting person under the Issuer's omnibus incentive plan in connection with the assumption of certain vested, in-the-money options held by reporting person under the incentive plan of Paragon Bioservices, Inc. coincident with that entity's acquisition by one of Issuer's subsidiaries. As reported in the Form 4 filed by the reporting person on May 21, 2019 that this Form 4/A is amending, the number of options and the exercise price thereof (originally 230,093 and $0.88, respectively) were subject to adjustment based on post-closing net purchase price adjustments. Those adjustments have resulted in additional value accruing to the reporting person, as reflected in the options' amended quantity and exercise price.
Documents
Issuer
Catalent, Inc.
CIK 0001596783
Entity typeother
Related Parties
1- filerCIK 0001252570
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 12:20 PM ET
- Size
- 6.4 KB